1. Home
  2. KRYS vs HWC Comparison

KRYS vs HWC Comparison

Compare KRYS & HWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • HWC
  • Stock Information
  • Founded
  • KRYS 2015
  • HWC 1883
  • Country
  • KRYS United States
  • HWC United States
  • Employees
  • KRYS N/A
  • HWC N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • HWC Major Banks
  • Sector
  • KRYS Health Care
  • HWC Finance
  • Exchange
  • KRYS Nasdaq
  • HWC Nasdaq
  • Market Cap
  • KRYS 4.3B
  • HWC 4.3B
  • IPO Year
  • KRYS 2017
  • HWC N/A
  • Fundamental
  • Price
  • KRYS $152.08
  • HWC $60.50
  • Analyst Decision
  • KRYS Strong Buy
  • HWC Buy
  • Analyst Count
  • KRYS 11
  • HWC 6
  • Target Price
  • KRYS $204.27
  • HWC $66.00
  • AVG Volume (30 Days)
  • KRYS 273.6K
  • HWC 880.9K
  • Earning Date
  • KRYS 08-04-2025
  • HWC 07-15-2025
  • Dividend Yield
  • KRYS N/A
  • HWC 2.97%
  • EPS Growth
  • KRYS 109.01
  • HWC 27.47
  • EPS
  • KRYS 4.16
  • HWC 5.42
  • Revenue
  • KRYS $333,448,000.00
  • HWC $1,410,490,000.00
  • Revenue This Year
  • KRYS $40.10
  • HWC $10.91
  • Revenue Next Year
  • KRYS $49.73
  • HWC $5.65
  • P/E Ratio
  • KRYS $36.60
  • HWC $11.20
  • Revenue Growth
  • KRYS 247.53
  • HWC 8.17
  • 52 Week Low
  • KRYS $122.80
  • HWC $43.90
  • 52 Week High
  • KRYS $213.52
  • HWC $62.90
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 58.86
  • HWC 57.10
  • Support Level
  • KRYS $147.35
  • HWC $59.67
  • Resistance Level
  • KRYS $154.99
  • HWC $62.90
  • Average True Range (ATR)
  • KRYS 4.29
  • HWC 1.48
  • MACD
  • KRYS 0.08
  • HWC -0.15
  • Stochastic Oscillator
  • KRYS 66.32
  • HWC 57.82

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About HWC Hancock Whitney Corporation

Hancock Whitney Corp operates bank offices and financial centers. The company offers a range of traditional and online banking services to commercial, small business, and retail customers, providing a variety of transaction and savings deposit products, treasury management services, secured and unsecured loan products (including revolving credit facilities), letters of credit, and similar financial guarantees. The Bank provides trust and investment management services to retirement plans, corporations, and individuals and provides its customers access to investment advisory and brokerage products.

Share on Social Networks: